SCHEMBL10044523

SCHEMBL10044523

COc1cc(C)c(CCCN2CCS(=O)(=O)CC2)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.44
EBP Q15125 3/20 0.44
HRH3 Q9Y5N1 2/20 0.44
LMNA P02545 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
CYP2D6 P10635 1/20 0.44
ADRA2C P18825 1/20 0.44
OPRK1 P41145 1/20 0.44
KCNH2 Q12809 1/20 0.44
CD274 Q9NZQ7 1/20 0.42
SLC6A4 P31645 1/20 0.41
MAPT P10636 3/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
FGFR1 P11362 1/20 0.36
FGFR2 P21802 1/20 0.36
FGFR4 P22455 1/20 0.36
FGFR3 P22607 1/20 0.36
KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15180045 0.85 SIGMAR1 (0.41) SIGMAR1EBPHRH3LMNAHTR1A
SCHEMBL28928134 0.68 CYP1A2 (0.39) KDM4EALDH1A1CYP19A1NQO2
SCHEMBL15672343 0.65 CYP1A2 (0.37) LMNAKDM4EALDH1A1CYP19A1NQO2
SCHEMBL13067435 0.65 ALDH1A1 (0.40) LMNAKDM4EALDH1A1CYP19A1NQO2
SCHEMBL14963168 0.64 ALDH1A1 (0.41) LMNAKDM4EALDH1A1CYP19A1NQO2
SCHEMBL13202682 0.64 HPGD (0.41) HRH3SLC6A4MAPTKDM4EALDH1A1
SCHEMBL13828731 0.64 CYP1A2 (0.44) LMNACD274KDM4EALDH1A1CYP19A1
SCHEMBL12551006 0.62 TSHR (0.49) LMNAHTR1AMAPTKDM4EALDH1A1
SCHEMBL12961532 0.62 SIGMAR1 (0.60) SIGMAR1EBPTMEM97
SCHEMBL806010 0.61 GNAI3 (0.41) SIGMAR1HTR1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012052420-A1 METHOD FOR PREPARING SUBSTITUTED N-(3-AMINO-QUINOXALIN-2-YL)-SULFONAMIDES AND THEIR INTERMEDIATES N-(3-CHLORO-QUINOXALIN-2-YL)SULFONAMIDES MERCK SERONO S.A. GENEVA (CH) 2012-04-26 WO disclosed